148 References
American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text rev.). Washington, DC: Author.
Spencer, J. P. (2010). The impact of fruit flavanoids on memory and cognition. British Journal of Nutrition, 104, suppl 3: S40-7.
van Holst, R.J., van den Brink, W., Veltman D.J, & Gourdriaan A.E. (2010). Brain imaging studies in pathological gambling. Current Psychiatric Reports, 12(5), 418-425.
Scammel, T.E., & Winrow, C.J. (2009). Orexin receptors : pharmacology and therapeutic opportunities. Annual Review of Pharmacology and Toxicology. 61.
Itokawa, K., Fukul, M., Ninomiya, M., Yamamoto, T., Imabayashi, E., Tamura, N., Matsuda, H., & Araki, N. (2010). Gabapentin for kleine-levin syndrome. Internal Medicine, 48(13), 1183-1185
Simeion, D., Guralnik, O., Schmeidler, J., & Knutleska, M. (2004). Fluxoetine therapy in depersonalization disorder: randomised controlled trial. The British Journal of Psychiatry: The Journal of Mental Science, 185, 31-36.
Labree, W., Nijman H., van Marie, H., & Rassin, E. (2010). Backgrounds and characteristics of arsonists. International Journal of Law and Psychiatry, 33(3), 149-153.
Berent, D., Florkowski, A., & Galecki, P. (2010). Muchausen syndrome by proxy. Psychiatry Polska,44(2), 245-254.
Arnulf I, Lin L, Gadoth N, File J, Lecendreux M, Franco P, Zeitzer J, Lo B, Faraco JH, Mignot E. (2008). Kleine-Levin syndrome: a systematic study of 108 patients. Ann Neurol 63(4):482-93
Arnulf I, Zeitzer JM, File J, Farber N, Mignot E. (2005). Kleine-Levin syndrome: a systematic review of 186 cases in the literature. Brain,128(Pt 12):2763-76
Mignot E, Lammers GJ, Ripley B, Okun M, Nevsimalova S, Overeem S, Vankova J, Black J, Harsh J, Bassetti C, Schrader H, Nishino S: The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol 2002; 59(10):1553-62
Mignot E, Lin L, Finn L, Lopes C, Pluff K, Sundstrom ML, Young T: Correlates of sleep-onset REM periods during the Multiple Sleep Latency Test in community adults. Brain 2006; 129(Pt 6):1609-23
Ohayon MM: From wakefulness to excessive sleepiness: what we know and still need to know. Sleep Med Rev 2008; 12(2):129-41
Ohayon MM, Priest RG, Caulet M, Guilleminault C: Hypnagogic and hypnopompic hallucinations: pathological phenomena? Br J Psychiatry 1996; 169(4):459-67
Aldrich MS, Chervin RD, Malow BA: Value of the multiple sleep latency test (MSLT) for the diagnosis of narcolepsy. Sleep 1997; 20(8):620-9
Bassetti C, Aldrich MS: Idiopathic hypersomnia. A series of 42 patients. Brain 1997; 120 ( Pt 8):1423-35
Bishop C, Rosenthal L, Helmus T, Roehrs T, Roth T: The frequency of multiple sleep onset REM periods among subjects with no excessive daytime sleepiness. Sleep 1996; 19(9):727-30
Carskadon MA, Dement WC, Mitler MM, Roth T, Westbrook PR, Keenan S: Guidelines for the multiple sleep latency test (MSLT): a standard measure of sleepiness. Sleep 1986; 9(4):519-24
Singh M, Drake CL, Roth T: The prevalence of multiple sleep-onset REM periods in a population-based sample. Sleep 2006; 29(7):890-5
American Academy of Medicine: ICSD-2. International Classification of Sleep Disorders, 2nd Edition: Diagnostic and Coding Manual. Westchester, Illinois, American Academy of Sleep Medicine, 2005
Markwowska, A.L. (1999). Sex dimorphisms in the rate of age-related decline in spatial memory: relevance to alterations in the estrous cycle. Journal of Neuroscience, 19(18), 8122-8133.
Salthouse, T.A. (2009). When does age-related cognitive decline begin?. Nuerobiological Aging, 30(4), 507-514.
Gualtieri, C.T., & Johnson, J.G. (2008). Age-related cognitive decline in patients with mood disorders. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 32, 962-967.
Dell’Osso, B., Altamura, A.C., Allen, A., Marazitti, D., & Hollander, E. (2006). Epidemiologic and clinical updates on impulse control disorders: a critical review. European Archives of Psychiatry and Neuroscience. 256(8), 464-475.
Kroenke, K.(2007). Efficacy of treatment for somatoform disorders: a review of randomized controlled trials. Psychosomatic Medicine, 69,881-888.
Sumathipala, A.(2007). What is the evidence for the efficacy of treatments for somatoform disorders? Psychosomatic Medicine, 69. 889-900.
Hiller, W., Rief, W., & Brahler, E. (2007). Somatization in the population: from mild body perceptions to disabling symptoms. Social Psychiatry and Psychiatric Epidemiology, 41(9), 704-712.
Zhang, Y.F., Ren, G.F., & Zhang, X.C. (2010). Acupuncture plus cupping for treating insomnia in college students. Journal of Traditional Chinese Medicine, 30 (3), 185-189.
Hallet, M & Wu, T. (2005). A functional MRI study of automatic movements in patients with parkinson’s disease, Brain, 128(10), 2250-2259.
Barsky, A. (1992). Amplification,somatization, and the somatoform disorders. Psychosomatics, 33, 28-34.
Harter,M., Baumeister, H., Reuter, K., Jacobi, F., Hofler, M., Bengel, J., & Wittchen, H. (2007). Increased 12-month prevalence rates of mental disorders in patients with chronic somatic diseases. Psychotherapy and Psychosomatics, 76, 354-360.
Keuthen, N.J., O’Sullivan, R.L., Hayday, C.F., Ricciardi, J.N., Buttolph, M.L., Jenike, M.A., & Baer, L. (1995). The massachusetts general hospital hairpulling scale 2: reliability and validity. Psychotherapy and Psychosomatics, 64(3-4), 146-148.
